115,000 Shares in Bovie Medical Co. (BVX) Purchased by Columbia Pacific Advisors LLC

Columbia Pacific Advisors LLC acquired a new stake in shares of Bovie Medical Co. (NYSEAMERICAN:BVX) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 115,000 shares of the medical device company’s stock, valued at approximately $574,000. Bovie Medical accounts for about 0.8% of Columbia Pacific Advisors LLC’s portfolio, making the stock its 21st largest holding.

Several other hedge funds have also modified their holdings of BVX. Acadian Asset Management LLC bought a new position in Bovie Medical in the 3rd quarter worth $226,000. Royce & Associates LP boosted its holdings in Bovie Medical by 3.4% in the 2nd quarter. Royce & Associates LP now owns 710,000 shares of the medical device company’s stock worth $3,088,000 after buying an additional 23,400 shares during the period. Boston Partners bought a new position in Bovie Medical in the 2nd quarter worth $620,000. Signaturefd LLC bought a new position in Bovie Medical in the 2nd quarter worth $136,000. Finally, Cowen Prime Services LLC boosted its holdings in Bovie Medical by 10.3% in the 2nd quarter. Cowen Prime Services LLC now owns 348,093 shares of the medical device company’s stock worth $1,514,000 after buying an additional 32,636 shares during the period.

Several research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Bovie Medical from a “buy” rating to a “hold” rating in a report on Monday, November 5th. Dougherty & Co assumed coverage on shares of Bovie Medical in a report on Friday, September 14th. They issued a “buy” rating and a $11.00 target price for the company. Finally, JMP Securities upped their target price on shares of Bovie Medical from $6.00 to $8.50 and gave the stock a “market outperform” rating in a report on Thursday, September 6th.

BVX opened at $7.27 on Tuesday. Bovie Medical Co. has a 52 week low of $2.28 and a 52 week high of $7.62.

Bovie Medical (NYSEAMERICAN:BVX) last released its quarterly earnings data on Thursday, November 1st. The medical device company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.08. The company had revenue of $3.67 million for the quarter, compared to the consensus estimate of $3.67 million. During the same period last year, the company earned ($0.09) EPS. The firm’s revenue for the quarter was up 38.5% on a year-over-year basis.

ILLEGAL ACTIVITY WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2018/12/04/115000-shares-in-bovie-medical-co-bvx-purchased-by-columbia-pacific-advisors-llc.html.

About Bovie Medical

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and technologies, and related medical products used in doctor's offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue.

Featured Article: What are retained earnings?

Want to see what other hedge funds are holding BVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bovie Medical Co. (NYSEAMERICAN:BVX).

Institutional Ownership by Quarter for Bovie Medical (NYSEAMERICAN:BVX)

Receive News & Ratings for Bovie Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bovie Medical and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit